Zobrazeno 1 - 10
of 399
pro vyhledávání: '"HER2 receptor"'
Publikováno v:
Asian Journal of Medical Sciences, Vol 13, Iss 7, Pp 87-91 (2022)
Background: Breast cancer is the most common cancer in female representing approximately 25% of all cancer. It is also ranked number one cancer among Indian females with ageadjusted incidence rate of 25.8 per 100,000 women and mortality 12.7 per 100,
Externí odkaz:
https://doaj.org/article/a8f2f14c9b0d4eb28eca703dafd8707b
Publikováno v:
Nanomedicine Journal, Vol 8, Iss 4, Pp 279-289 (2021)
Objective(s): Successful detection of tumors in the early stages can significantly increase a patient’s healing process and recovery speed. Conventional imaging techniques usually depend on the tissues’ anatomical structure. Epidermal growth fact
Externí odkaz:
https://doaj.org/article/3c35a8d12f8a4a21b49233ee7fee4732
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Olga Cruz-López, Matilde Ner, Francho Nerín-Fonz, Yaiza Jiménez-Martínez, David Araripe, Juan A. Marchal, Houria Boulaiz, Hugo Gutiérrez-de-Terán, Joaquín M. Campos, Ana Conejo-García
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 36, Iss 1, Pp 1551-1561 (2021)
A series of 11 new substituted 1,5-dihydro-4,1-benzoxazepine derivatives was synthesised to study the influence of the methyl group in the 1-(benzenesulphonyl) moiety, the replacement of the purine by the benzotriazole bioisosteric analogue, and the
Externí odkaz:
https://doaj.org/article/bcda5ad136ca41fa807513d29c5746ae
Autor:
Chuner Jiang, Peng Wu, Xiangming He, Jianfen Ni, Xiaowen Ding, Xiaohong Xu, Fangzheng Wang, Dehong Zou
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Background and ObjectivesReproductive hormones and receptors play crucial roles in breast cancer development and progression. The association between preoperative serum reproductive hormone levels and receptor status in postmenopausal women with brea
Externí odkaz:
https://doaj.org/article/205bb92bee324821a2927195120792f4
Autor:
Ali Alhuseinalkhudhur, Mark Lubberink, Henrik Lindman, Vladimir Tolmachev, Fredrik Y. Frejd, Joachim Feldwisch, Irina Velikyan, Jens Sörensen
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract Background High expression of human epidermal growth factor receptor type 2 (HER2) represents an aggressive subtype of breast cancer. Anti-HER2 treatment requires a theragnostic approach wherein sufficiently high receptor expression in biops
Externí odkaz:
https://doaj.org/article/4caad0730afa49ddb24302d540d2e961
Autor:
Theja Settem, Vijayalakshmi Devi Bodagala, K Hari Kishore, Pavan Kumar G. Kale, A Y Lakshmi, Mutheeshwaraiah Yootla, Narendra Hulikal, Rukmangada Nandyala
Publikováno v:
Journal of Dr. NTR University of Health Sciences, Vol 9, Iss 4, Pp 241-244 (2020)
Context: Classic prognostic markers in breast cancer are tumor size and grade, lymph node status, molecular markers, including estrogen receptor (ER), progesterone receptor (PR), Ki-67 index, human growth factor receptor 2 (HER2) protein, and angioge
Externí odkaz:
https://doaj.org/article/36a7f600a3744704bdbaedacceeff513
Autor:
Nikolina Dukić, Zdenka Gojković, Nenad Lalović, Jelena Vladičić-Mašić, Dragana Jokanović, Srdjan Mašić, Sladjana Popović, Olivera Čančar
Publikováno v:
Biomedicinska istraživanja, Vol 10, Iss 1, Pp 83-90 (2019)
The human epidermal growth receptor 2 (HER2, c-erb-B2) is present in 15-20% of breast cancer at the time of diagnosis. Overexpression of HER2 receptor is associated with more aggressive form of breast cancer. Trastuzumab is a human monoclonal antibo
Externí odkaz:
https://doaj.org/article/bff3329202734a4d8d38e6696ff2251b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
EJNMMI Research, Vol 8, Iss 1, Pp 1-6 (2018)
Abstract Background Assessment of the status of tumor biomarkers in individual patients would facilitate personalizing treatment strategy, and continuous monitoring of those biomarkers and their binding process to the therapeutic drugs would provide
Externí odkaz:
https://doaj.org/article/90c68c33b56f4edd9a089ed8851dd26e